| Date Filed | Type | Description |
| 12/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 15,000 options to buy
@ $26.43, valued at
$396.5k
|
|
| 07/02/2019 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,890 shares
@ $0 |
|
| 08/30/2018 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 15,000 options to buy
@ $20, valued at
$300k
|
|
| 06/04/2018 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Converted 15,000 shares
@ $13.6, valued at
$204k
Converted 15,000 options to buy
@ $13.6, valued at
$204k
|
|
| 01/27/2016 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 15,000 options to buy
@ $5.15, valued at
$77.3k
|
|
| 08/26/2015 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 24,000 options to buy
@ $4, valued at
$96k
|
|
| 11/25/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 4,499 shares
@ $39.356, valued at
$177.1k
|
|
| 11/21/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 5,000 shares
@ $39.095, valued at
$195.5k
|
|
| 11/19/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 301 shares
@ $39, valued at
$11.7k
|
|
| 11/14/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 2,000 shares
@ $39, valued at
$78k
Sold 2,200 shares
@ $39.4682, valued at
$86.8k
Sold 1,000 shares
@ $39, valued at
$39k
|
|
| 11/05/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 15,000 options to buy
@ $0.83, valued at
$12.5k
|
|
| 01/21/2014 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 10,000 options to buy
@ $1.71, valued at
$17.1k
|
|
| 01/20/2010 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 09/11/2009 |
4
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP |